文献速递眼底病与葡萄膜炎

ORCA研究:新生血管性年龄相关性黄斑变性疾病活动度的真实世界与阅片中心评估对比

ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD).
PubMed 文献 · Br J Ophthalmol · 2020-02-17

ORCA研究是OCEAN研究的前瞻性非干预模块,评估德国临床医生对新生血管性年龄相关性黄斑变性(nAMD)患者SD-OCT图像解读及治疗决策的质量及其对24个月视力结局的影响。共纳入205只眼的2286次SD-OCT扫描,由临床医生和阅片中心(RC)独立评估脉络膜新生血管(CNV)活动体征。RC在69.0%的扫描中检测到CNV活动,临床医生为60.9%,一致率74.9%。在RC检测到CNV活动的扫描中,临床医生仅对35.5%执行了抗VEGF注射。结论认为,尽管对CNV活动参数广泛一致,正确识别CNV活动并不总是导致启动(再)治疗。

要点

  • RC检测到CNV活动的比例为69.0%,临床医生为60.9%,两者一致率为74.9%。
  • 在RC检测到CNV活动的扫描中,仅35.5%的病例临床医生执行了抗VEGF注射。
  • 在RC检测到CNV活动但临床医生认为无需治疗的病例中,约2/3的病例临床医生正确检测到了CNV活动。

核心结论

  • 尽管临床医生与阅片中心对CNV活动参数有广泛一致,但正确识别CNV活动并不总是导致启动或再次治疗。
  • 为长期保持视力,需要正确解读SD-OCT扫描并谨慎做出再治疗决策。

研究设计与样本

  • ORCA模块是OCEAN研究的前瞻性、非干预性研究,评估德国临床医生对SD-OCT图像解读及治疗决策的质量。
  • 共纳入205只眼的2286次SD-OCT扫描,由临床医生和阅片中心独立评估CNV活动体征。

主要发现

  • RC检测到CNV活动的扫描为1578次(69.0%),临床医生检测到1392次(60.9%),一致率为74.9%。
  • 在RC检测到CNV活动的1578次扫描中,临床医生仅执行了560次(35.5%)抗VEGF注射。
  • 在311次(19.7%)未治疗病例中,理由为患者要求、终止标准或无其他CNV活动体征的慢性囊样空间。
  • 在707次(44.8%)RC检测到CNV活动的病例中,临床医生声称无需治疗,尽管其中约2/3的病例正确检测到了CNV活动。
  • 在 presumed undertreatment 的病例中,34%在后续访视中视力下降。

关键数值与推荐

  • CNV活动定义为存在视网膜内液、视网膜下液和/或色素上皮脱离增加。

临床怎么用

  • 临床医生应提高对SD-OCT上CNV活动体征的识别,并在识别后及时启动或调整抗VEGF治疗。
  • 对于检测到CNV活动但认为无需治疗的情况,需谨慎评估以避免治疗不足导致视力下降。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: The prospective, non-interventional ORCA module of the OCEAN study (Observation of Treatment Patterns with Lucentis in Approved Indications) evaluated the qualiy of spectral domain-optical coherence tomography (SD-OCT) image interpretation and treatment decisions by clinicians in Germany and the impact on visual outcomes over 24 months in patients with neovascular age-related macular degeneration (nAMD). METHODS: 2286 SD-OCT scans of 205 eyes were independently evaluated by clinicians and reading centres (RCs) regarding signs of choroidal neovascularisation (CNV) activity, including presence of intraretinal fluid, subretinal fluid, and/or increase in pigment epithelial detachments. Agreement between clinicians and RCs was calculated. Treatment decisions by clinicians and the impact on treatment outcomes were evaluated. RESULTS: CNV activity was detected by RCs on 1578 scans (69.0%) and by clinicians on 1392 scans (60.9%), with agreement in 74.9% of cases. Of the 1578 scans with RC detected CNV activity, anti-vascular endothelial growth factor injections were performed by clinicians in only 35.5% (560/1578). In 19.7% of cases (311/1578), lack of treatment was justified by patients request, termination criteria or chronic cystoid spaces without other signs for CNV activity. In 44.8% of cases (707/1578) with RC detected CNV activity, clinicians claimed no treatment was necessary despite having correctly detected CNV activity in about 2/3 of these cases. In 34% of cases with presumed undertreatment, visual acuity declined in the following visit. CONCLUSION: Although broad agreement on CNV activity parameters was observed between clinicians and RCs, correct identification of CNV activity did not always lead to the initiation of (re-)treatment. To preserve vision over time, correct interpretation of SD-OCT scans and careful retreatment decisions are required. TRIAL REGISTRATION NUMBER: NCT02194803.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Liakopoulos S, Spital G, Brinkmann CK, et al. ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD). Br J Ophthalmol. 2020. PMID: 32066561. doi:10.1136/bjophthalmol-2019-315717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。